New Data for Genentech's Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration 05 September
Roche receives CE IVDR approval for HER2 companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients 05 September
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension 30 August
